Download FREE Report Sample
Download Free sampleThe prostate is a walnut-sized gland located behind the base of a man?s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
Prostate Cancer Diagnostics Market contains market size and forecasts of Prostate Cancer Diagnostics in Global, including the following market information:
Global Prostate Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate Cancer Diagnostics market was valued at 13820 million in 2021 and is projected to reach US$ 22870 million by 2028, at a CAGR of 7.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tumor Biomarker Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnostics include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
Tumor Biomarker Tests
Imaging
Biopsy
Other
Global Prostate Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
Age Below 55
Age 55-75
Age Above 75
Global Prostate Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostate Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
